SV BR1 GM breast cancer vaccine companion diagnostic - Briacell TherapeuticsAlternative Names: BriaDx™; BriaVax™ companion diagnostic - briacell; BriaVax™ DX -Briacell
Latest Information Update: 02 Dec 2016
At a glance
- Originator BriaCell Therapeutics Corp
- Class Cancer vaccines; Gene therapies; Immunotherapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer